Infigratinib
| CAS No. | 872511-34-7 |
|---|---|
| MDL No. | MFCD22123241 |
| MF | C26H31Cl2N7O3 |
| MW | 560.50 |
| InChI Key | QADPYRIHXKWUSV-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
BGJ-398 is a phenylurea in which a hydrogen on one nitrogen is replaced by a 2,6-dichloro-3,5-dimethoxyphenyl group, and the other nitrogen is substituted with a methyl group and a 6-{[4-(4-ethylpiperazin-1-yl)phenyl]amino}pyrimidin-4-yl group. It is a potent and selective fibroblast growth factor receptor inhibitor, functioning as a fibroblast growth factor receptor antagonist and an antineoplastic agent. It belongs to the classes of aminopyrimidine, N-arylpiperazine, N-alkylpiperazine, dichlorobenzene, and phenylureas.
| CAS No. | 872511-34-7 |
|---|---|
| Product Name | Infigratinib |
Biological Targets
FGFR3·FGFR1·FGFR4·FGFR2
Associated Conditions
human papilloma virus infection·neoplasm·breast cancer·oropharynx squamous cell carcinoma·head and neck squamous cell carcinoma·
* The information provided here is compiled from public sources and is for reference only.
